Oncolin Therapeutics Inc. says that its board has set a new strategic direction for the company to focus on acquiring and developing assets that are associated with renewable and traditional energy resources through its subsidiary, New EnerSource.
New EnerSource was initially formed to develop and procure enhanced oil recovery technologies and develop international hydrocarbon projects focusing on new technologies that were in the early development phase. However, the new direction of New EnerSource will be to focus on more mature renewable energy projects, such as wind and solar developments.
SOURCE: Oncolin Therapeutics
